108 related articles for article (PubMed ID: 6747349)
1. (2'-5')oligo(A) synthetase as a monitor of interferon action in juvenile laryngeal papillomatosis.
Lodemann E; Kornhuber B; Gerein V; von Il'berg C
J Interferon Res; 1984; 4(2):283-90. PubMed ID: 6747349
[TBL] [Abstract][Full Text] [Related]
2. Serum interferon level and (2'-5')oligoadenylate synthetase activity in lymphocytes during clinical interferon application.
Lodemann E; Nitsche EM; Lang MH; Gerein V; Altmeyer P; Holzmann H; Kornhuber B
J Interferon Res; 1985; 5(4):621-8. PubMed ID: 2418131
[TBL] [Abstract][Full Text] [Related]
3. [Results of long-term leukocyte interferon (alpha IFN) therapy using an individually determined dose schedule in recurrent laryngeal papillomatosis].
Gerein V; Lodemann E; Bell G; von Ilberg C; Kornhuber B
Klin Padiatr; 1987; 199(3):224-9. PubMed ID: 3114545
[TBL] [Abstract][Full Text] [Related]
4. Monitoring of interferon treatment in patients with renal cell carcinoma and bladder carcinoma by oligo-A synthetase assay and determination of immunological parameters.
Grups JW; Komprecht B
J Biol Regul Homeost Agents; 1989; 3(3):98-101. PubMed ID: 2516404
[TBL] [Abstract][Full Text] [Related]
5. 2',5'-Oligoadenylate synthetase activity in peripheral blood lymphocytes as a clinical marker in interferon therapy for chronic hepatitis B.
Furuta M; Akashi K; Nakamura Y; Matsumoto K; Yamaguchi H; Takamatsu S; Shimizu T
J Interferon Res; 1987 Feb; 7(1):111-9. PubMed ID: 3585079
[TBL] [Abstract][Full Text] [Related]
6. [Effect of alpha-leukocyte interferon on laryngeal papillomatosis in children].
Vacher S; Peytral C; Narcy P
Presse Med; 1985 Jun; 14(24):1317-8. PubMed ID: 3161020
[TBL] [Abstract][Full Text] [Related]
7. Interferon therapy in juvenile laryngeal papillomatosis.
Lundquist PG; Haglund S; Carlsöö B; Strander H; Lundgren E
Otolaryngol Head Neck Surg; 1984 Aug; 92(4):386-91. PubMed ID: 6207477
[TBL] [Abstract][Full Text] [Related]
8. Combined CO2-laser and alfa recombinant interferon treatment in five children with juvenile laryngeal papillomatosis.
Mattot M; Ninane J; Hamoir M; Moulin D; Mustin V; Vermylen C; Cornu G
Acta Clin Belg; 1990; 45(3):158-63. PubMed ID: 2166413
[TBL] [Abstract][Full Text] [Related]
9. Induction of 2'-5' oligoadenylate synthetase during interferon treatment of chronic myelogenous leukemia.
Moritz T; Weissmann B; Grünewald B; Hust H; Kummer G; Niederle N
Mol Biother; 1992 Jun; 4(2):97-102. PubMed ID: 1381190
[TBL] [Abstract][Full Text] [Related]
10. Interferon-induced 2'-5' oligoadenylate synthetase during interferon-alpha therapy in homosexual men with Kaposi's sarcoma: marked deficiency in biochemical response to interferon in patients with acquired immunodeficiency syndrome.
Preble OT; Rook AH; Steis R; Silverman RH; Krause D; Quinnan GV; Masur H; Jacob J; Longo D; Gelmann EP
J Infect Dis; 1985 Sep; 152(3):457-65. PubMed ID: 2993441
[TBL] [Abstract][Full Text] [Related]
11. Biological and clinical effects of the combination of beta- and gamma-interferons administered as a 5-day continuous infusion.
Schiller JH; Storer B; Witt PL; Nelson B; Brown RR; Horisberger M; Grossberg S; Borden EC
Cancer Res; 1990 Aug; 50(15):4588-94. PubMed ID: 2114942
[TBL] [Abstract][Full Text] [Related]
12. (2'-5') Oligo A synthetase in human polymorphonuclear cells increased activity in interferon treatment and in viral infections.
Schattner A; Merlin G; Bregman V; Hahn T; Levin S; Revel M; Wallach D
Clin Exp Immunol; 1984 Aug; 57(2):265-70. PubMed ID: 6467673
[TBL] [Abstract][Full Text] [Related]
13. Interferon and 2',5'-oligo(A) synthetase activities in serum and blood mononuclear leukocytes of cattle after injection of bovine interferon-alpha 1.
Perino LJ; Short EC; Burge LJ; Winter DA; Fulton RW
Am J Vet Res; 1990 Jun; 51(6):886-92. PubMed ID: 1695068
[TBL] [Abstract][Full Text] [Related]
14. Immunological recovery and dose evaluation in IFN-alpha treatment of hairy cell leukemia: analysis of leukocyte differentiation antigens, NK and 2',5'-oligoadenylate synthetase activity.
Nielsen B; Hokland M; Justesen J; Hasselbalch H; Ellegaard J; Hokland P
Eur J Haematol; 1989 Jan; 42(1):50-9. PubMed ID: 2914594
[TBL] [Abstract][Full Text] [Related]
15. High level activity of 2', 5'-oligoadenylate synthetase in dog serum.
Iwata A; Yamamoto A; Fujino M; Sato I; Hosokawa-Kanai T; Tuchiya K; Ishihama A; Sokawa Y
J Vet Med Sci; 2004 Jun; 66(6):721-4. PubMed ID: 15240951
[TBL] [Abstract][Full Text] [Related]
16. Lightmicroscopical features of interferon-alpha-treated laryngeal papillomatosis in adults.
Bomholt A; Oestergaard B; Horn T
Acta Otolaryngol; 1986; 102(1-2):131-5. PubMed ID: 3739686
[TBL] [Abstract][Full Text] [Related]
17. Changes of serum 2',5'-oligoadenylate synthetase activity during interferon treatment of chronic hepatitis C.
Solinas A; Cossu P; Poddighe P; Tocco A; Deplano A; Garrucciu G; Diana MS
Liver; 1993 Oct; 13(5):253-8. PubMed ID: 8259037
[TBL] [Abstract][Full Text] [Related]
18. A phase I study of recombinant interferon-beta in patients with advanced malignant disease.
Ravandi F; Estrov Z; Kurzrock R; Breitmeyer JB; Maschek BJ; Talpaz M
Clin Cancer Res; 1999 Dec; 5(12):3990-8. PubMed ID: 10632330
[TBL] [Abstract][Full Text] [Related]
19. Interferon therapy for laryngeal papillomatosis in adults.
Bomholt A
Arch Otolaryngol; 1983 Aug; 109(8):550-2. PubMed ID: 6870649
[TBL] [Abstract][Full Text] [Related]
20. Measurement of 2',5'-oligoadenylate synthetase in patients receiving interferon-alpha.
Merritt JA; Borden EC; Ball LA
J Interferon Res; 1985; 5(1):191-8. PubMed ID: 3989336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
